ProShares Ultra Nasdaq Biotechnology BIB
Set alert
120.53 USD +0.37 +0.31%
At close · Oct 30
120.53 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
120.00 Day range 125.27
67.50 52-week range 126.40
- YTD
- +51.08%
- 1 year
- +72.58%
- Open
- 122.20
- Prev close
- 120.16
- Mkt cap
- 103.65M
- Vol
- 27.13K
- Avg vol
- 9.81K
- EPS
- 3.53
- P/E
- 34.13
- Div yield
- 0.00%
More statistics
- Low
- 120.00
- High
- 125.27
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 59.52
- 200-d avg
- 59.79
30m chart
Built from the cached five-day intraday bars.
Signals (10)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 9:55 AM | 2 days ago |
| RSI: Overbought | Oct 30, 9:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:55 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:55 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 10:55 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:55 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:55 AM | 5 days ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 59.52
- 200-day average
- 59.79
About ProShares Ultra Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
News
- Capital Investment Advisors LLC Acquires New Holdings in ProShares Ultra Nasdaq Biotechnology $BIB
- ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving Average – What’s Next?
- ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Cross Above 50 Day Moving Average – Here’s Why
- BIB: A Tactical 2 X Leveraged Biotech ETF
- Wall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
- 3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
- Equity CEFs/ETFs: Top Picks For 2024 - Part II
- Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine
- The 7 Best ETFs to Buy to Cover 2023's Biggest Investing Opportunities
- The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Your note
Sign in to keep a note on BIB — it syncs with the Stock Master app.